Chief Medical Officer Paul Kelly has responded to concerns over the Oxford-AstraZeneca COVID-19 vaccine arguing that once regulators approve the vaccine, Australia will be a prime position to achieve herd immunity.
Some of Australia’s medical community have raised concerns that the AstraZeneca vaccine does not meet the efficacy standards to effectively counter the CCP virus citing a report published in The Lancet in December 2020 that said the vaccine efficacy ranged from 62 to 90 percent.
